Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2007, Article ID 30578, 7 pages
http://dx.doi.org/10.1155/2007/30578
Review Article

Muscle-Specific PPARβ/δ Agonism May Provide Synergistic Benefits with Life Style Modifications

Department of Internal Medicine, Faculty of Medicine, Celal Bayar University, Manisa 45040, Turkey

Received 2 July 2007; Revised 8 August 2007; Accepted 13 November 2007

Academic Editor: Jihan Youssef

Copyright © 2007 Adnan Erol. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Gaudel and P. A. Grimaldi, “Metabolic functions of peroxisome proliferator-activated receptor β/δ in skeletal muscle,” PPAR Research, vol. 2007, Article ID 86394, 6 pages, 2007. View at Publisher · View at Google Scholar · View at PubMed
  2. Y.-X. Wang, C.-L. Zhang, and R. T. Yu et al., “Regulation of muscle fiber type and running endurance by PPARδ,” PLoS Biology, vol. 2, no. 10, pp. 1532–1539, 2004. View at Publisher · View at Google Scholar · View at PubMed
  3. G. D. Barish, V. A. Narkar, and R. M. Evans, “PPARδ: a dagger in the heart of the metabolic syndrome,” Journal of Clinical Investigation, vol. 116, no. 3, pp. 590–597, 2006. View at Publisher · View at Google Scholar · View at PubMed
  4. C. K. Roberts and R. J. Barnard, “Effects of exercise and diet on chronic disease,” Journal of Applied Physiology, vol. 98, no. 1, pp. 3–30, 2005. View at Publisher · View at Google Scholar · View at PubMed
  5. F. W. Booth and R. A. Shanely, “The biochemical basis of the health effects of exercise: an integrative view,” in Proceedings of the Nutrition Society, vol. 63, no. 2, pp. 199–203, Columbia, Mo, USA, May 2004. View at Publisher · View at Google Scholar
  6. T. R. Koves, P. Li, and J. An et al., “Peroxisome proliferator-activated receptor-γ co-activator 1α-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency,” Journal of Biological Chemistry, vol. 280, no. 39, pp. 33588–33598, 2005. View at Publisher · View at Google Scholar · View at PubMed
  7. A. P. Russell, J. Feilchenfeldt, and S. Schreiber et al., “Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-γ coactivator-1 and peroxisome proliferator-activated receptor-α in skeletal muscle,” Diabetes, vol. 52, no. 12, pp. 2874–2881, 2003. View at Publisher · View at Google Scholar
  8. S. Trappe, M. Harber, and A. Creer et al., “Single muscle fiber adaptations with marathon training,” Journal of Applied Physiology, vol. 101, no. 3, pp. 721–727, 2006. View at Publisher · View at Google Scholar · View at PubMed
  9. E. Volpi, R. Nazemi, and S. Fujita, “Muscle tissue changes with aging,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 7, no. 4, pp. 405–410, 2004. View at Publisher · View at Google Scholar
  10. D. Freyssenet, “Energy sensing and regulation of gene expression in skeletal muscle,” Journal of Applied Physiology, vol. 102, no. 2, pp. 529–540, 2007. View at Publisher · View at Google Scholar · View at PubMed
  11. A. Leal-Cerro, A. Gippini, and M. J. Amaya et al., “Mechanisms underlying the neuroendocrine response to physical exercise,” Journal of Endocrinological Investigation, vol. 26, no. 9, pp. 879–885, 2003.
  12. J. Mercier, A. Perez-Martin, X. Bigard, and R. Ventura, “Muscle plasticity and metabolism: effects of exercise and chronic diseases,” Molecular Aspects of Medicine, vol. 20, no. 6, pp. 319–373, 1999. View at Publisher · View at Google Scholar
  13. A. G. Smith and G. E. O. Muscat, “Skeletal muscle and nuclear hormone receptors: Implications for cardiovascular and metabolic disease,” International Journal of Biochemistry and Cell Biology, vol. 37, no. 10, pp. 2047–2063, 2005. View at Publisher · View at Google Scholar · View at PubMed
  14. D. Pette, H. Peuker, and R. S. Staron, “The impact of biochemical methods for single muscle fibre analysis,” Acta Physiologica Scandinavica, vol. 166, no. 4, pp. 261–277, 1999. View at Publisher · View at Google Scholar
  15. J. He, S. Watkins, and D. E. Kelley, “Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity,” Diabetes, vol. 50, no. 4, pp. 817–823, 2001. View at Publisher · View at Google Scholar
  16. J. Norrbom, C. J. Sundberg, H. Ameln, W. E. Kraus, E. Jansson, and T. Gustafsson, “PGC-1α mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle,” Journal of Applied Physiology, vol. 96, no. 1, pp. 189–194, 2004. View at Publisher · View at Google Scholar · View at PubMed
  17. K. Baar, A. R. Wende, and T. E. Jones et al., “Adaptations of skeletal muscle to exercise: Rapid increase in the transcriptional coactivator PGC-1,” FASEB Journal, vol. 16, no. 14, pp. 1879–1886, 2002. View at Publisher · View at Google Scholar · View at PubMed
  18. S.-H. Koo, H. Satoh, and S. Herzig et al., “PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3,” Nature Medicine, vol. 10, no. 5, pp. 530–534, 2004. View at Publisher · View at Google Scholar · View at PubMed
  19. H. Liang and W. F. Ward, “PGC-1α: a key regulator of energy metabolism,” Advances in Physiology Education, vol. 30, no. 4, pp. 145–151, 2006. View at Publisher · View at Google Scholar · View at PubMed
  20. E. Hondares, I. Pineda-Torra, R. Iglesias, B. Staels, F. Villarroya, and M. Giralt, “PPARδ, but not PPARα, activates PGC-1α gene transcription in muscle,” Biochemical and Biophysical Research Communications, vol. 354, no. 4, pp. 1021–1027, 2007. View at Publisher · View at Google Scholar · View at PubMed
  21. S. Luquet, J. Lopez-Soriano, and D. Holst et al., “Peroxisome proliferator-activated receptor δ controls muscle development and oxidative capability,” FASEB Journal, vol. 17, no. 15, pp. 2299–2301, 2003. View at Publisher · View at Google Scholar · View at PubMed
  22. P. Garcia-Roves, J. M. Huss, and D.-H. Han et al., “Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 25, pp. 10709–10713, 2007. View at Publisher · View at Google Scholar · View at PubMed
  23. R. M. Evans, G. D. Barish, and Y.-X. Wang, “PPARs and the complex journey to obesity,” Nature Medicine, vol. 10, no. 4, pp. 355–361, 2004. View at Publisher · View at Google Scholar · View at PubMed
  24. O. Barbier, I. P. Torra, and Y. Duguay et al., “Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 5, pp. 717–726, 2002. View at Publisher · View at Google Scholar
  25. S. Luquet, J. Lopez-Soriano, and D. Holst et al., “Roles of peroxisome proliferator-activated receptor delta (PPARδ) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome,” Biochimie, vol. 86, no. 11, pp. 833–837, 2004. View at Publisher · View at Google Scholar · View at PubMed
  26. D. M. Muoio, D. B. MacLean, and D. B. Lang et al., “Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) α knock-out mice. Evidence for compensatory regulation by PPARδ,” Journal of Biological Chemistry, vol. 277, no. 29, pp. 26089–26097, 2002. View at Publisher · View at Google Scholar · View at PubMed
  27. U. Dressel, T. L. Allen, J. B. Pippal, P. R. Rohde, P. Lau, and G. E.O. Muscat, “The peroxisome proliferator-activated receptor β/δ agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells,” Molecular Endocrinology, vol. 17, no. 12, pp. 2477–2493, 2003. View at Publisher · View at Google Scholar · View at PubMed
  28. O. Braissant, F. Foufelle, C. Scotto, M. Dauça, and W. Wahli, “Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat,” Endocrinology, vol. 137, no. 1, pp. 354–366, 1996. View at Publisher · View at Google Scholar
  29. M. Schuler, F. Ali, and C. Chambon et al., “PGC1α expression is controlled in skeletal muscles by PPARβ, whose ablation results in fiber-type switching, obesity, and type 2 diabetes,” Cell Metabolism, vol. 4, no. 5, pp. 407–414, 2006. View at Publisher · View at Google Scholar · View at PubMed
  30. Y.-X. Wang, C.-H. Lee, S. Tiep, R. T. Yu, J. Ham, H. Kang, and R. M. Evans, “Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity,” Cell, vol. 113, no. 2, pp. 159–170, 2003. View at Publisher · View at Google Scholar
  31. E. Barton and C. Morris, “Mechanisms and strategies to counter muscle atrophy,” Journals of Gerontology—Series A Biological Sciences and Medical Sciences, vol. 58, no. 10, pp. 923–926, 2003.
  32. J. Lexell and D. Downham, “what is the effect of aging on type 2 muscle fiber?,” Journals of Neurol Science, vol. 107, no. 2, pp. 250–251, 1992.
  33. M. R. Deschenes, “Effects of aging on muscle fiber type and size,” Sports Medicine, vol. 34, no. 12, pp. 809–824, 2004.
  34. K. E. Conley, S. A. Jubrias, C. E. Amara, and D. J. Marcinek, “Mitochondrial dysfunction: impact on exercise performance and cellular aging,” Exercise and Sport Sciences Reviews, vol. 35, no. 2, pp. 43–49, 2007. View at Publisher · View at Google Scholar · View at PubMed
  35. Z. Arany, N. Lebrasseur, and C. Morris et al., “The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle,” Cell Metabolism, vol. 5, no. 1, pp. 35–46, 2007. View at Publisher · View at Google Scholar · View at PubMed
  36. C. Ling, P. Poulsen, and E. Carlsson et al., “Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins,” Journal of Clinical Investigation, vol. 114, no. 10, pp. 1518–1526, 2004. View at Publisher · View at Google Scholar
  37. Y. Kamei, H. Ohizumi, and Y. Fujitani et al., “PPARγ coactivator 1β/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 21, pp. 12378–12383, 2003.
  38. A. Oberbach, Y. Bossenz, and S. Lehmann et al., “Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes,” Diabetes Care, vol. 29, no. 4, pp. 895–900, 2006.
  39. G. E. O. Muscat and U. Dressel, “Cardiovascular disease and PPARδ: targeting the risk factors,” Current Opinion in Investigational Drugs, vol. 6, no. 9, pp. 887–894, 2005.
  40. L. Cheng, G. Ding, and Q. Qin et al., “Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy,” Nature Medicine, vol. 10, no. 11, pp. 1245–1250, 2004. View at Publisher · View at Google Scholar · View at PubMed
  41. A. Planavila, R. Rodríguez-Calvo, M. Jové, L. Michalik, W. Wahli, J. C. Laguna, and M. Vázquez-Carrera, “Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes,” Cardiovascular Research, vol. 65, no. 4, pp. 832–841, 2005. View at Publisher · View at Google Scholar · View at PubMed
  42. T. Takahashi, T. Tanaka, and J. Sakai, “New therapeutic target for metabolic syndrome: PPARδ,” Endocrine Journal, vol. 54, no. 3, pp. 347–357, 2007. View at Publisher · View at Google Scholar
  43. T. Tanaka, S. Yamamoto, and H. Iwasaki et al., “Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 26, pp. 15924–15929, 2003.
  44. K. C. Choi, S. Y. Lee, and H. J. Yoo et al., “Effect of PPAR-δ agonist on the expression of visfatin, adiponectin, and resistin in rat adipose tissue and 3T3-L1 adipocytes,” Biochemical and Biophysical Research Communications, vol. 357, no. 1, pp. 62–67, 2007. View at Publisher · View at Google Scholar · View at PubMed
  45. C. Fürnsinn, T. M. Willson, and B. Brunmair, “Peroxisome proliferator-activated receptor-δ, a regulator of oxidative capacity, fuel switching and cholesterol transport,” Diabetologia, vol. 50, no. 1, pp. 8–17, 2007. View at Publisher · View at Google Scholar · View at PubMed
  46. U. Seedorf and J. Aberle, “Emerging roles of PPARδ in metabolism,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1771, no. 9, pp. 1125–1131, 2007. View at Publisher · View at Google Scholar · View at PubMed
  47. Y. Barak, D. Liao, and W. He et al., “Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 303–308, 2002. View at Publisher · View at Google Scholar · View at PubMed
  48. M. A. Peraza, A. D. Burdick, H. E. Marin, F. J. Gonzalez, and J. M. Peters, “The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR),” Toxicological Sciences, vol. 90, no. 2, pp. 269–295, 2006. View at Publisher · View at Google Scholar · View at PubMed
  49. T.-C. He, T. A. Chan, B. Vogelstein, and K. W. Kinzler, “PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs,” Cell, vol. 99, no. 3, pp. 335–345, 1999. View at Publisher · View at Google Scholar
  50. B. H. Park, B. Vogelstein, and K. W. Kinzler, “Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 5, pp. 2598–2603, 2001. View at Publisher · View at Google Scholar · View at PubMed
  51. F. S. Harman, C. J. Nicol, H. E. Marin, J. M. Ward, F. J. Gonzalez, and J. M. Peters, “Peroxisome proliferator-activated receptor-δ attenuates colon carcinogenesis,” Nature Medicine, vol. 10, no. 5, pp. 481–483, 2004.
  52. H. E. Marin, M. A. Peraza, and A. N. Billin et al., “Activation of peroxisome proliferator-activated receptor β inhibits colon carcinogenesis,” Cancer Research, vol. 66, no. 8, pp. 4394–4401, 2006. View at Publisher · View at Google Scholar · View at PubMed
  53. R. L. Stephen, M. C. U. Gustafsson, and M. Jarvis et al., “Activation of peroxisome proliferator-activated receptor δ stimulates the proliferation of human breast and prostate cancer cell lines,” Cancer Research, vol. 64, no. 9, pp. 3162–3170, 2004.
  54. L. Xu, C. Han, and T. Wu, “A novel positive feedback loop between peroxisome proliferator-activated receptor-δ and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth,” Journal of Biological Chemistry, vol. 281, no. 45, pp. 33982–33996, 2006. View at Publisher · View at Google Scholar · View at PubMed
  55. A. Erol, “Insulin resistance is an evolutionarily conserved physiological mechanism at the cellular level for protection against increased oxidative stress,” BioEssays, vol. 29, no. 8, pp. 811–818, 2007. View at Publisher · View at Google Scholar · View at PubMed